VIB is a life sciences research institute based in Flanders, Belgium, founded in 1995 as a non-profit by the Flemish government. The organization operates across multiple sites including Ghent and Leuven, partnering with Flemish universities such as KU Leuven, Ghent University, and University of Antwerp. With over 1,900 researchers, VIB conducts fundamental molecular research spanning cancer, immunology, neuroscience, plant biology, microbiology, and computational biology.
The institute's work in nanobody technology has led to advances in diagnostics and therapeutics, and it maintains bio-incubators in Ghent and Leuven to support life sciences ventures. VIB has produced numerous successful spin-off companies, translating discoveries from bench to application. The organization operates in industry verticals including biotechnology, health, environment, diagnostics, and therapeutics.
For security professionals considering a role here, the threat model is shaped by the nature of research data: genomic datasets, proprietary molecular research, intellectual property tied to spin-offs, and sensitive diagnostic and therapeutic development pipelines. Computational biology infrastructure and the interface between academic partnerships and commercial spin-offs create a complex data governance landscape. The attack surface includes collaboration platforms across university networks, bio-incubator environments supporting early-stage companies, and the translational pipeline from fundamental research to commercial application.
